Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy | Zendy

Fernando C. Fervenza | Zendy; Gerald B. Appel | Zendy; Sean J. Barbour | Zendy; Brad H. Rovin | Zendy; Richard Lafayette | Zendy; Nabeel Aslam | Zendy; Jonathan Ashley Jefferson | Zendy; Patrick E. Gipson | Zendy; Dana V. Rizk | Zendy; John R. Sedor | Zendy; James F. Simon | Zendy; Ellen T. McCarthy | Zendy; Paul Brenchley | Zendy; Sanjeev Sethi | Zendy; Carmen Ávila-Casado | Zendy; Heather Beanlands | Zendy; John C. Lieske | Zendy; David Philibert | Zendy; Tingting Li | Zendy; Leslie F. Thomas | Zendy; Dolly F. Green | Zendy; Luis A. Juncos | Zendy; Lada BearaLasić | Zendy; Samuel S. Blumenthal | Zendy; Amy N. Sussman | Zendy; Stephen B. Erickson | Zendy; Michelle Hladunewich | Zendy; Pietro A. Canetta | Zendy; Lee A. Hebert | Zendy; Nelson Leung | Zendy; Jay Radhakrishnan | Zendy; Heather N. Reich | Zendy; Samir V. Parikh | Zendy; Debbie S. Gipson | Zendy; Dominic K. Lee | Zendy; Bruno R. da Costa | Zendy; Peter Jüni | Zendy; Daniel Cattran | Zendy

AI Assistant Blog Pricing

Open Access

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Author(s) -

Fernando C. Fervenza,

Gerald B. Appel,

Sean J. Barbour,

Brad H. Rovin,

Richard Lafayette,

Nabeel Aslam,

Jonathan Ashley Jefferson,

Patrick E. Gipson,

Dana V. Rizk,

John R. Sedor,

James F. Simon,

Ellen T. McCarthy,

Paul Brenchley,

Sanjeev Sethi,

Carmen Ávila-Casado,

Heather Beanlands,

John C. Lieske,

David Philibert,

Tingting Li,

Leslie F. Thomas,

Dolly F. Green,

Luis A. Juncos,

Lada BearaLasić,

Samuel S. Blumenthal,

Amy N. Sussman,

Stephen B. Erickson,

Michelle Hladunewich,

Pietro A. Canetta,

Lee A. Hebert,

Nelson Leung,

Jay Radhakrishnan,

Heather N. Reich,

Samir V. Parikh,

Debbie S. Gipson,

Dominic K. Lee,

Bruno R. da Costa,

Peter Jüni,

Daniel Cattran

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1814427

Subject(s) - rituximab , membranous nephropathy , medicine , immunology , antibody , glomerulonephritis , kidney

B-cell anomalies play a role in the pathogenesis of membranous nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for inducing and maintaining a complete or partial remission of proteinuria in patients with this condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog